BIOS Capital Management, LP
CIK 1813845
Transactions on file
38
Open-market buys
1
Win rate (buys)
0%
1 scored
Avg % since filing (buys)
-78.9%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-17 | CGTX COGNITION THERAPEUTICS INC | Director10% | Grant | 25,000 | $0.00 | — | open → |
| 2025-05-29 | 2025-05-28 | LTRN Lantern Pharma Inc. | 10% | Sale | 1,632 | $4.7K | +41.8% | open → |
| 2025-05-29 | 2025-05-28 | LTRN Lantern Pharma Inc. | 10% | Sale | 2,702 | $7.8K | +41.8% | open → |
| 2025-05-29 | 2025-05-29 | LTRN Lantern Pharma Inc. | 10% | Sale | 3,639 | $11.0K | +34.3% | open → |
| 2025-05-29 | 2025-05-27 | LTRN Lantern Pharma Inc. | 10% | Sale | 6,479 | $19.8K | +33.4% | open → |
| 2025-05-29 | 2025-05-28 | LTRN Lantern Pharma Inc. | 10% | Sale | 4,620 | $13.3K | +41.8% | open → |
| 2025-05-29 | 2025-05-29 | LTRN Lantern Pharma Inc. | 10% | Sale | 6,221 | $18.8K | +34.3% | open → |
| 2025-05-29 | 2025-05-27 | LTRN Lantern Pharma Inc. | 10% | Sale | 1,000 | $3.0K | +33.4% | open → |
| 2025-05-29 | 2025-05-28 | LTRN Lantern Pharma Inc. | 10% | Sale | 714 | $2.0K | +41.8% | open → |
| 2025-05-29 | 2025-05-29 | LTRN Lantern Pharma Inc. | 10% | Sale | 961 | $2.9K | +34.3% | open → |
| 2025-05-29 | 2025-05-27 | LTRN Lantern Pharma Inc. | 10% | Sale | 7,478 | $22.8K | +33.4% | open → |
| 2025-05-29 | 2025-05-28 | LTRN Lantern Pharma Inc. | 10% | Sale | 5,332 | $15.3K | +41.8% | open → |
| 2025-05-29 | 2025-05-29 | LTRN Lantern Pharma Inc. | 10% | Sale | 7,180 | $21.8K | +34.3% | open → |
| 2025-05-29 | 2025-05-27 | LTRN Lantern Pharma Inc. | 10% | Sale | 2,290 | $7.0K | +33.4% | open → |
| 2025-05-29 | 2025-05-27 | LTRN Lantern Pharma Inc. | 10% | Sale | 3,790 | $11.6K | +33.4% | open → |
| 2025-05-29 | 2025-05-29 | LTRN Lantern Pharma Inc. | 10% | Sale | 2,199 | $6.7K | +34.3% | open → |
| 2025-06-13 | 2025-06-11 | LTRN Lantern Pharma Inc. | 10% | Sale | 293 | $996.20 | +19.7% | open → |
| 2025-06-13 | 2025-06-12 | LTRN Lantern Pharma Inc. | 10% | Sale | 18,678 | $63.1K | +20.4% | open → |
| 2025-06-13 | 2025-06-11 | LTRN Lantern Pharma Inc. | 10% | Sale | 45 | $153.00 | +19.7% | open → |
| 2025-06-13 | 2025-06-12 | LTRN Lantern Pharma Inc. | 10% | Sale | 2,886 | $9.8K | +20.4% | open → |
| 2025-06-13 | 2025-06-10 | LTRN Lantern Pharma Inc. | 10% | Sale | 5 | $17.00 | +19.7% | open → |
| 2025-06-13 | 2025-06-11 | LTRN Lantern Pharma Inc. | 10% | Sale | 338 | $1.1K | +19.7% | open → |
| 2025-06-13 | 2025-06-12 | LTRN Lantern Pharma Inc. | 10% | Sale | 21,557 | $72.9K | +20.4% | open → |
| 2025-06-13 | 2025-06-10 | LTRN Lantern Pharma Inc. | 10% | Sale | 2 | $6.80 | +19.7% | open → |
| 2025-06-13 | 2025-06-11 | LTRN Lantern Pharma Inc. | 10% | Sale | 103 | $350.20 | +19.7% | open → |
| 2025-06-13 | 2025-06-12 | LTRN Lantern Pharma Inc. | 10% | Sale | 6,601 | $22.3K | +20.4% | open → |
| 2025-06-13 | 2025-06-10 | LTRN Lantern Pharma Inc. | 10% | Sale | 3 | $10.20 | +19.7% | open → |
| 2025-06-13 | 2025-06-11 | LTRN Lantern Pharma Inc. | 10% | Sale | 171 | $581.40 | +19.7% | open → |
| 2025-06-13 | 2025-06-12 | LTRN Lantern Pharma Inc. | 10% | Sale | 10,925 | $36.9K | +20.4% | open → |
| 2025-06-13 | 2025-06-10 | LTRN Lantern Pharma Inc. | 10% | Sale | 5 | $17.00 | +19.7% | open → |
| 2025-06-13 | 2025-06-10 | LTRN Lantern Pharma Inc. | 10% | Sale | 1 | $3.40 | +19.7% | open → |
| 2025-06-13 | 2025-06-13 | LTRN Lantern Pharma Inc. | 10% | Sale | 7,206 | $22.3K | +31.7% | open → |
| 2025-06-13 | 2025-06-13 | LTRN Lantern Pharma Inc. | 10% | Sale | 14,218 | $43.9K | +31.7% | open → |
| 2025-06-13 | 2025-06-13 | LTRN Lantern Pharma Inc. | 10% | Sale | 1,903 | $5.9K | +31.7% | open → |
| 2025-06-13 | 2025-06-13 | LTRN Lantern Pharma Inc. | 10% | Sale | 4,354 | $13.5K | +31.7% | open → |
| 2025-06-13 | 2025-06-13 | LTRN Lantern Pharma Inc. | 10% | Sale | 12,319 | $38.1K | +31.7% | open → |
| 2025-06-20 | 2025-06-18 | CGTX COGNITION THERAPEUTICS INC | Director10% | Grant | 34,000 | $0.00 | — | open → |
| 2025-06-30 | 2025-06-27 | ACTU ACTUATE THERAPEUTICS, INC. | Director10% | Buy | 71,428 | $500.0K | -78.9% | open → |
